Market Tracker

04/17 6:05pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.66
Data as of Apr 17
 0.00 / 0.00%
Today’s Change
1.11
Today|||52-Week Range
3.31
-19.81%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.66
Today’s open1.65
Day’s range1.64 - 1.68
Volume447,316
Average volume (3 months)1,038,767
Market cap$256.0M
Dividend yield--
Data as of 4:06pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)-8.57%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
THLDThreshold Pharmaceut...-0.19-4.73%
GALEGalena Biopharma Inc-0.06-3.23%
MRTXMirati Therapeutics ...+0.31+1.65%
CCXIChemoCentryx Inc+0.05+0.94%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateApril 30, 2014
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Jerome Pykett
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts